BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

269 related articles for article (PubMed ID: 32172730)

  • 21. Peptides specific to the galectin-3 carbohydrate recognition domain inhibit metastasis-associated cancer cell adhesion.
    Zou J; Glinsky VV; Landon LA; Matthews L; Deutscher SL
    Carcinogenesis; 2005 Feb; 26(2):309-18. PubMed ID: 15528216
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Galectin-3 and cancer stemness.
    Nangia-Makker P; Hogan V; Raz A
    Glycobiology; 2018 Apr; 28(4):172-181. PubMed ID: 29315388
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Galectin-3 promotes caspase-independent cell death of HIV-1-infected macrophages.
    Xue J; Fu C; Cong Z; Peng L; Peng Z; Chen T; Wang W; Jiang H; Wei Q; Qin C
    FEBS J; 2017 Jan; 284(1):97-113. PubMed ID: 27981746
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Roles of galectin-3 in metabolic disorders and tumor cell metabolism.
    Li YS; Li XT; Yu LG; Wang L; Shi ZY; Guo XL
    Int J Biol Macromol; 2020 Jan; 142():463-473. PubMed ID: 31604080
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Immunhistochemical expression of galectin-3 in cancer: a review of the literature.
    Cay T
    Turk Patoloji Derg; 2012; 28(1):1-10. PubMed ID: 22207425
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Galectin-3: an open-ended story.
    Dumic J; Dabelic S; Flögel M
    Biochim Biophys Acta; 2006 Apr; 1760(4):616-35. PubMed ID: 16478649
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Assembly, organization and regulation of cell-surface receptors by lectin-glycan complexes.
    Elola MT; Blidner AG; Ferragut F; Bracalente C; Rabinovich GA
    Biochem J; 2015 Jul; 469(1):1-16. PubMed ID: 26173257
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Impact of nuclear galectin-3 expression on histological differentiation and vascular invasion in patients with esophageal squamous cell carcinoma.
    Shibata T; Noguchi T; Takeno S; Takahashi Y; Fumoto S; Kawahara K
    Oncol Rep; 2005 Feb; 13(2):235-9. PubMed ID: 15643504
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Galectin-3 in cancer.
    Song L; Tang JW; Owusu L; Sun MZ; Wu J; Zhang J
    Clin Chim Acta; 2014 Apr; 431():185-91. PubMed ID: 24530298
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Unraveling galectin-1 as a novel therapeutic target for cancer.
    Astorgues-Xerri L; Riveiro ME; Tijeras-Raballand A; Serova M; Neuzillet C; Albert S; Raymond E; Faivre S
    Cancer Treat Rev; 2014 Mar; 40(2):307-19. PubMed ID: 23953240
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Varied expression and localization of multiple galectins in different cancer cell lines.
    Satelli A; Rao PS; Gupta PK; Lockman PR; Srivenugopal KS; Rao US
    Oncol Rep; 2008 Mar; 19(3):587-94. PubMed ID: 18288388
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Tyrosine-phosphorylated galectin-3 protein is resistant to prostate-specific antigen (PSA) cleavage.
    Balan V; Nangia-Makker P; Kho DH; Wang Y; Raz A
    J Biol Chem; 2012 Feb; 287(8):5192-8. PubMed ID: 22232548
    [TBL] [Abstract][Full Text] [Related]  

  • 33. CD29 and CD7 mediate galectin-3-induced type II T-cell apoptosis.
    Fukumori T; Takenaka Y; Yoshii T; Kim HR; Hogan V; Inohara H; Kagawa S; Raz A
    Cancer Res; 2003 Dec; 63(23):8302-11. PubMed ID: 14678989
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The Role of Galectin-1 in Cancer Progression, and Synthetic Multivalent Systems for the Study of Galectin-1.
    Cousin JM; Cloninger MJ
    Int J Mol Sci; 2016 Sep; 17(9):. PubMed ID: 27649167
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Galectin-3 overexpression protects from apoptosis by improving cell adhesion properties.
    Matarrese P; Fusco O; Tinari N; Natoli C; Liu FT; Semeraro ML; Malorni W; Iacobelli S
    Int J Cancer; 2000 Feb; 85(4):545-54. PubMed ID: 10699929
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Galectin-3 interacts with components of the nuclear ribonucleoprotein complex.
    Fritsch K; Mernberger M; Nist A; Stiewe T; Brehm A; Jacob R
    BMC Cancer; 2016 Jul; 16():502. PubMed ID: 27435226
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Sialylation regulates galectin-3/ligand interplay during mammary tumour progression--a case of targeted uncloaking.
    de Oliveira JT; de Matos AJ; Santos AL; Pinto R; Gomes J; Hespanhol V; Chammas R; Manninen A; Bernardes ES; Albuquerque Reis C; Rutteman G; Gärtner F
    Int J Dev Biol; 2011; 55(7-9):823-34. PubMed ID: 22161838
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The role of galectin-3 in promotion of the inflammatory response.
    Liu FT; Hsu DK
    Drug News Perspect; 2007 Sep; 20(7):455-60. PubMed ID: 17992268
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Galectin-3 expression and secretion by tumor-associated macrophages in hypoxia promotes breast cancer progression.
    Wang L; Li YS; Yu LG; Zhang XK; Zhao L; Gong FL; Yang XX; Guo XL
    Biochem Pharmacol; 2020 Aug; 178():114113. PubMed ID: 32579956
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Human Galectin-1 in Multiple Cancers: A Privileged Molecular Target in Oncology.
    Goud NS; Bhattacharya A
    Mini Rev Med Chem; 2021; 21(15):2169-2186. PubMed ID: 33596802
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.